<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04290208</url>
  </required_header>
  <id_info>
    <org_study_id>F/N-R19-3892BLP</org_study_id>
    <nct_id>NCT04290208</nct_id>
  </id_info>
  <brief_title>A Comparison of IV Versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section</brief_title>
  <official_title>A Comparison of IV Versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Main Line Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sharpe-Strumia Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Main Line Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled study will compare narcotic consumption between two groups:
      patients that receive a perioperative dose of IV acetaminophen versus patients that receive a
      perioperative dose of oral liquid acetaminophen for scheduled cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      &quot;Enhanced recovery&quot; is an alternate management protocol described by a multi-modal, evidence
      based approach to peri-operative care, with the goal of accelerating recovery and return to
      normal activity after surgery. Results have shown stable pain control with a decrease in
      narcotic consumption, a quicker return of bowel function, and decreased length of hospital
      stay and cost with no change in level of patient satisfaction, morbidity, or readmission
      rate. An aspect of some alternate management protocols is the administration of
      acetaminophen.

      The concentration of acetaminophen in cerebrospinal fluid (CSF) is directly proportional to
      the analgesic activity of acetaminophen. Acetaminophen relies on a high concentration
      gradient from the plasma to the CSF in order to passively diffuse into the central nervous
      system (CNS), its principal site of action. A 2012 study, comparing plasma and CSF
      pharmacokinetics of intravenous (IV), oral (PO), or rectal (PR) acetaminophen, concluded that
      IV administration of acetaminophen results in higher plasma and CSF concentration values.
      Therefore, IV acetaminophen produces better CNS penetration compared to PO or PR methods.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 22, 2019</start_date>
  <completion_date type="Anticipated">June 23, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 23, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>When the Principal Investigator calls to enroll patient into the study, pharmacy will be responsible for labelling and delivering the drugs to the labor and delivery unit. The label will include the patient enrollment number and the study name. The investigators will be blind to the patient's drug/placebo assignment. In case of emergency, side effects, or allergic reaction, the pharmacy will be contacted to unblind medication.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Narcotic Utilization</measure>
    <time_frame>6 hours post operative</time_frame>
    <description>The Center for Disease Control and Prevention Morphine Milligram Equivalent Score will be used to calculate total narcotic use (conversion factor for administered opioid x milligrams administered) while the patient remains as an inpatient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pain Level</measure>
    <time_frame>Every hour for six hours post-op</time_frame>
    <description>Pain will be measured via the visual analog Postoperative Pain Scale and gathered by nursing. The visual analogue Postoperative Pain Scale indicates the level of pain the patient is feeling or felt in the indicated period from 0 (no pain) to 100 (the worst pain possible).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Patient satisfaction will be assessed using the validated survey used in the Mayo Clinical Trial.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications during the inpatient stay</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Postoperative complications will be noted during the inpatient stay.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Cesarean Section</condition>
  <condition>Acetaminophen</condition>
  <arm_group>
    <arm_group_label>Intravenous Administration of Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A single peri-operative dose of acetaminophen 1000 mg IV over 15 minutes after skin is closed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Per Oral Administration of Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A pre-operative liquid dose of acetaminophen 1000mg orally in the on-call to Operative Room.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>IV Acetaminophen</description>
    <arm_group_label>Intravenous Administration of Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Acetaminophen liquid syrup</description>
    <arm_group_label>Per Oral Administration of Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Flavored, non-medicated (placebo) liquid syrup</description>
    <arm_group_label>Intravenous Administration of Acetaminophen</arm_group_label>
    <other_name>Placebo for acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>IV salt solution (non-medicated)</description>
    <arm_group_label>Per Oral Administration of Acetaminophen</arm_group_label>
    <other_name>Placebo for acetaminophen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women age 18 or older

          -  Scheduled to undergo a cesarean section

        Exclusion Criteria:

          -  Existing diagnosis of chronic pain

          -  Need to undergo a vertical skin incision

          -  Aspartate Aminotransferase (AST) &gt; 50, alanine aminotransferase (ALT) &gt; 70

          -  Platelets below 80,000 on admission

          -  Need to undergo general anesthesia

          -  Tubal ligation at time of Cesarean section

          -  Prior or known allergy to any of the medications being utilized in this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dmitri Chamchad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Main Line Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Day, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bryn Mawr Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dmitri Chamchad, MD</last_name>
    <phone>610-355-9451</phone>
    <email>chamchad@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lankenau Medical Center</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Bowden</last_name>
      <phone>484-476-2692</phone>
      <email>Dbowden@mlhs.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Nelson G, Kalogera E, Dowdy SC. Enhanced recovery pathways in gynecologic oncology. Gynecol Oncol. 2014 Dec;135(3):586-94. doi: 10.1016/j.ygyno.2014.10.006. Epub 2014 Oct 12. Review.</citation>
    <PMID>25316179</PMID>
  </reference>
  <results_reference>
    <citation>Singla NK, Parulan C, Samson R, Hutchinson J, Bushnell R, Beja EG, Ang R, Royal MA. Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract. 2012 Sep;12(7):523-32. doi: 10.1111/j.1533-2500.2012.00556.x. Epub 2012 Apr 24.</citation>
    <PMID>22524979</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 14, 2019</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Main Line Health</investigator_affiliation>
    <investigator_full_name>Dmitri Chamchad</investigator_full_name>
    <investigator_title>Anesthesia Research Director</investigator_title>
  </responsible_party>
  <keyword>Humans</keyword>
  <keyword>Female</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Narcotics</keyword>
  <keyword>Patient Satisfaction</keyword>
  <keyword>Cesarean Section</keyword>
  <keyword>Pain</keyword>
  <keyword>Postoperative Period</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

